Prognostic significance of serum c-erbB-2 protein in breast cancer patients
- 1 October 1996
- journal article
- other
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 40 (3) , 251-255
- https://doi.org/10.1007/bf01806813
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Detection of C-ERBB-2 Related Protein in Sera from Breast Cancer Patients Relationship to ERBB2 gene amplification and c-erbB-2 protein overexpression in tumourActa Oncologica, 1995
- Soluble c-erbB-2 fragment in serum correlates with disease stage and predicts for shortened survival in patients with early-stage and advanced breast cancerBritish Journal of Cancer, 1994
- Relationship between EGF-R, c-erbB-2 protein expression and Ki67 immunostaining in breast cancer and hormone sensitivityEuropean Journal Of Cancer, 1993
- Determination of a fragment of the c-erbB-2 translational product p185 in serum of breast cancer patientsZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neuBreast Cancer Research and Treatment, 1992
- C-erbB-2 protein in the sera of breast cancer patientsBreast Cancer Research and Treatment, 1992
- Clinical and pathologic significance of the c-erbB-2 (HER-2/neu) oncogene.1992
- c-erbB-2 oncoprotein expression in primary and advanced breast cancerBritish Journal of Cancer, 1991
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- Evaluation of an enzyme immunoassay for estrogen receptors in human breast cancers.1986